Fig. 2From: Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)FFPE rhabdomyosarcoma patient samples stained for ASPP2κ protein expression, using an isoform-specific antibody (ab#5385 [13]) (B-E), (A) Normal placenta tissue served as a negative control. (10 × magnification, zoom 100x) Back to article page